Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, November 24, 2021
[ Wed, Nov 24th 2021
] - WOPRAI
[ Wed, Nov 24th 2021
] - WOPRAI
[ Wed, Nov 24th 2021
] - WOPRAI
[ Wed, Nov 24th 2021
] - WOPRAI
[ Wed, Nov 24th 2021
] - WOPRAI
[ Wed, Nov 24th 2021
] - WOPRAI
[ Wed, Nov 24th 2021
] - WOPRAI
[ Wed, Nov 24th 2021
] - WOPRAI
[ Wed, Nov 24th 2021
] - WOPRAI
[ Wed, Nov 24th 2021
] - WOPRAI
[ Wed, Nov 24th 2021
] - WOPRAI
[ Wed, Nov 24th 2021
] - WOPRAI
[ Wed, Nov 24th 2021
] - WOPRAI
[ Wed, Nov 24th 2021
] - WOPRAI
[ Wed, Nov 24th 2021
] - WOPRAI
[ Wed, Nov 24th 2021
] - WOPRAI
[ Wed, Nov 24th 2021
] - WOPRAI
[ Wed, Nov 24th 2021
] - WOPRAI
Tue, November 23, 2021
[ Tue, Nov 23rd 2021
] - WOPRAI
[ Tue, Nov 23rd 2021
] - WOPRAI
[ Tue, Nov 23rd 2021
] - WOPRAI
[ Tue, Nov 23rd 2021
] - WOPRAI
[ Tue, Nov 23rd 2021
] - WOPRAI
[ Tue, Nov 23rd 2021
] - WOPRAI
[ Tue, Nov 23rd 2021
] - WOPRAI
Francois Brisebois Initiated (TARS) at Buy and Held Target at $55 on, Nov 23rd, 2021
Francois Brisebois of Oppenheimer, Initiated "Tarsus Pharmaceuticals, Inc." (TARS) at Buy and Held Target at $55 on, Nov 23rd, 2021.
Francois has made no other calls on TARS in the last 4 months.
There is 1 other peer that has a rating on TARS. Out of the 1 peers that are also analyzing TARS, 0 agree with Francois's Rating of Hold.
This is the rating of the analyst that currently disagrees with Francois
- Dane Leone of "Raymond James" Maintained at Strong Buy with Increased Target to $65 on, Friday, October 8th, 2021
